Optimizing Nephron Performance: The Old, the New, and the New-Old Diuretic Therapies

Flavio D Fuchs1,2, Guilherme S Procianoy1, Leonardo G Bottino1,2

  • 1Division of Cardiology, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-903, Brazil.

Biomedicines
|June 26, 2025
PubMed

Insights

Diuretics, both old and new, effectively manage hypertension, heart failure, and chronic kidney disease (CKD). Recent evidence highlights the efficacy of older agents like chlorthalidone and acetazolamide, alongside newer drugs such as gliflozins.

Area of Science:

  • Nephrology
  • Cardiology
  • Pharmacology

Background:

  • Pharmacological interventions targeting nephron function significantly impact hypertension, heart failure, and chronic kidney disease (CKD).
  • Diuretics represent a cornerstone therapy, with ongoing research exploring both established and novel agents.

Purpose of the Study:

  • To review the efficacy of traditional and newer diuretics in managing hypertension, heart failure, and CKD.
  • To highlight emerging evidence on the effectiveness of established diuretic agents.

Main Methods:

  • Review of existing literature, including randomized controlled trials and nonrandomized studies.
  • Analysis of data on thiazide, loop, potassium-sparing diuretics, indapamide, gliflozins, chlorthalidone, and acetazolamide.

Main Results:

  • Established diuretics (thiazides, loop diuretics) show efficacy in heart failure and CKD, with randomized trials confirming their role in preventing cardiovascular disease.
  • Potassium-sparing agents mitigate thiazide side effects and reduce cardiovascular events in heart failure.
  • Newer agents like gliflozins offer novel mechanisms for managing heart failure and slowing CKD progression, irrespective of diabetes status.
  • Recent studies demonstrate significant blood pressure reduction with chlorthalidone in advanced CKD and accelerated clinical control with acetazolamide in acute heart failure.

Conclusions:

  • Both established and novel diuretics play crucial roles in managing cardiovascular and kidney diseases.
  • Emerging evidence reinforces the value of older diuretic agents, while newer drugs offer distinct therapeutic advantages.
  • Future research should explore combination therapies to optimize nephron function and patient outcomes.

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
505
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
890
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
795
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
51
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
69
Physiology of the Genitourinary System III: Urine Concentration and Dilution01:20

Physiology of the Genitourinary System III: Urine Concentration and Dilution

The kidneys concentrate or dilute urine to maintain water and electrolyte balance. Nephrons, particularly the loop of Henle, play a crucial role in this process through the countercurrent multiplication system. This system establishes a high osmolarity in the renal medulla, which is essential for water reabsorption. In the loop of Henle’s descending limb, water is reabsorbed into the surrounding medulla due to its permeability to water. In contrast, the ascending limb actively transports...
49